The Road to Adoption: Bringing Cutting-Edge Diagnostics to Market

In this episode of The Promise of Personalized Medicine, Perry sits down with Jonathan Romanowksy, Co-Founder and Chief Business Officer at Inflammatix, Inc. 

With years of experience in the field, Jonathan shares insights into how personalized medicine is expanding beyond oncology and transplantation into new areas such as infectious diseases, neurology, and immunology.

They dive into the challenges and opportunities of bringing innovative diagnostic tools to market, ensuring clinical adoption, and overcoming payer skepticism. The conversation also touches on the critical role of integrated health delivery systems, group purchasing organizations, and the payer community in facilitating the adoption of novel medical technologies. Jonathan provides thought-provoking insights on the need for a more proactive approach from payers, including the implementation of coverage-with-evidence development programs to evaluate and support new innovations.

Key Topics Discussed:

• Sepsis and Acute Infection Management – The critical need for better diagnostic tools and how TriVerity is making an impact
• Clinical Study Rigor – Why broad, well-designed studies are essential for test adoption and payer reimbursement
• Payer Considerations in Precision Medicine – Balancing innovation with cost-effectiveness and scalability
• Early Adoption of Diagnostic Testing – Challenges and strategies for integrating a newly FDA-cleared test into healthcare systems.
• Impact on Patient Care – How the test can help hospitals decide whether to transfer patients, reducing unnecessary transfers and improving outcomes.
• Value-Based Care and Pricing Models – The potential for pricing medical products based on the value they bring rather than traditional reimbursement structures.
• Future of Healthcare Innovation – The need for better collaboration between payers, providers, and innovators to improve patient care and system efficiency.

Tune in as they discuss the challenges of reimbursement models, the potential for value-based pricing, and how the healthcare system can work towards a future where the right patient receives the right care at the right time.

—-------

Stay connected with our host, Perry Dimas, here on LinkedIn!